.png)
%201%20(1).png)
24 million people die each year from 1 of 7 chronic diseases
>3 Billion
People worldwide have 1 of these 7 diseases.
>2 Billion
Don’t know they have the disease.
>4 Years
Average time from disease onset to diagnosis.
$2.5 Trillion
Spent annually treating these 7 diseases.
$525 Billion
Spent each year diagnosing these diseases—too late.
$1Trillion+
Saved by diagnosing better and earlier
• Type 2 Diabetes
• Coronary Artery Disease
• Chronic Obstructive Pulmonary Disease
• Congestive Heart Failure
• Cognitive Decline
• Chronic Kidney Disease
• Chronic Liver Disease
Traditional diagnostics are broken. Infinite Epigenetics is diagnostics reimagined.
Radically Affordable &
Scalable
Thousands of health markers and measurement of major chronic diseases with a few drops of blood
Predictive & Preventative
Epigenetic technology detects and predicts disease before clinical symptoms arise
Starting with the top chronic diseases affecting 3B+ people worldwide
Proprietary Algorithms & AI
Proprietary algorithms developed with top researchers
Improving exponentially via AI, deepening predictive power over time
Traditional Diagnostics
Expensive & Inaccessible
Traditional diagnostics require multiple costly tests, labs, and specialists, resulting in trillions spent annually.
Radically Affordable &
Scalable
Traditional diagnostics require multiple costly tests, labs, and specialists, resulting in trillions spent annually.
Traditional Diagnostics
Reactive, Not Predictive
Diagnosis typically occurs after symptoms appear, often too late to prevent disease progression.
Predictive & Preventative
Epigenetic technology detects and predicts disease before clinical symptoms arise
Starting with the top chronic diseases affecting 3B+ people worldwide
Traditional Diagnostics
Inconvenient & Inaccessible
Time-consuming in-lab blood draws, delayed results, and disconnected patient experience.
Proprietary Algorithms & AI
Proprietary algorithms developed with top researchers
Improving exponentially via AI, deepening predictive power over time
AI + Epigenetics are converging to make what was once impossible, possible
Epigenetics Is No Longer Experimental
Epigenetics is the science of gene expression, shaped by lifestyle, aging, stress, and environmental factors
DNA is 10% of your health. Epigenetics are the other 90%
Predicts disease years before symptoms, enabling true detection not just prevention
25+ peer-reviewed studies with top institutions have validated the science
Artificial Intelligence & Falling Compute Costs
AI is now powerful enough to make sense of vast health
Cost of compute has dropped by 80%+
Infinite’s LLM-driven system learns from every test, improving insights over time
Infinite owns the largest DNA methylation database in the world, training our models for unparalleled precision
120+ Interventional Trials with Pharma, Academic & Life Science Partners
.png)
.png)
.png)
.png)
The power behind Infinite Epigenetics
Every test we run improves future value, creating a competitive advantage that compounds as we grow.
More Adoption
Smarter Models
More data
More Adoption
1,500+
Custom predictive algorithms
Proprietary models for pace of aging, chronic disease risk and more
100,000
Proprietary epigenetic samples
Largest private dataset of DNA methylation samples linked to aging & disease
2M
Public + external methylation tests
Integrated reference data across diseases, aging, nutrition, and health states
∞
Data Flywheel
Every test improves future insights—building a continuously learning system
Developed with the top minds in science
Partnering with 115+ leading research institutions including Harvard, Yale, Duke, and Cambridge to show you how your unique biology changes over time.
37
MD + PHDs
Who worked on the science behind Infinite Epigenetics
115+
Research partnerships
With leading universities like Harvard, Yale, and Duke
6T+
Human Data Points
Analyzed and used to create Infinite algorithms
1M+
DNA SITES
Measured in every test, giving you the most precise health insights
Scientific Advisory Board
Jessica Lasky Su, PhD
Harvard University
.png)
Raghav Sehgal, PhD
Yale University
.png)
Michael Corley, PhD
UC San Diego
.png)
Andrew Teschendorff, PhD
University of Cambridge
.png)
Wanding Zhou, PhD
Van Andel Institute
.png)
Albert Higgins-Chen
Yale University
.webp)
.webp)
Led by a proven founding team with $20B+ in exits
Matt Dawson, MD
Co-Founder,
Chief Executive Officer
Chief Executive Officer
6x founder with multiple exits
Author of 2 medical textbooks & 100+ chapters
National award for “Innovation in Healthcare”
Sought-after public speaker on precision medicine, AI in healthcare, and the future of diagnostics
.png){kind=avatar}
Brad Keywell
Co-Founder,
Board Member
Board Member
EY World Entrepreneur of the Year
Raised $4B+ in capital over the last decade
Serial entrepreneur with multiple $B exits (Groupon, Tempus AI, Echo Global Logistics, Uptake, etc.)
Co-founded 9 technology companies, an early stage VC firm, a global ideas platform, and several nonprofits.
.png){kind=avatar}
Mike Mallin, MD
Co-Founder,
Chief Science Officer
Chief Science Officer
2x healtcare founder with multiple exits
Chief Medical Officer for Bryan Johnson
Author of 50+ peer-reviewed publications
Renowned educator on genomics, longevity, and system-based health
Founded 10+ companies
$20B+ in total exits
Authored 2 textbooks
National awards for innovation
50+ peer-reviewed studies published
Run by world class operators
Our operating team has deep expertise in healthtech, having founded, led and scaled multiple companies to success.
.png){kind=avatar}
.png){kind=avatar}
.png){kind=avatar}
.png){kind=avatar}
Infinite Epigenetics is disrupting a $525 billion market
Infinite Epigenetics
Grail
Delfi
Cologuard
Published Algorithms
Types of Analysis
Methylation
Methylation
Genetic
Methylation & Mutation
Data Testing Size
(CpGs + SNPs)
1,000,000+
Not Published
Not Published
11
Number of
Biomarker Outputs
110+
50
1
1
Collections Method
Blood
Blood
Blood
Stool